FDA Adverse Event Malfunction Summary report: N

RELION PRIME TEST STRIPS

MDR report key: 14208900 · Received April 26, 2022

Report

Report Number
1832816-2022-00004
Event Type
Malfunction
Date Received
April 26, 2022
Date of Event
March 3, 2022
Report Date
April 19, 2022
Manufacturer
ARKRAY FACTORY USA, INC.
Product Code
CGA
UDI-DI
00605388022943
PMA / PMN Number
K091102/001
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CT, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

CUSTOMER RETURNED TWO BOTTLES OF SPECIFIED STRIPS. BOTTLE 1 WAS RETURNED WITH 46 STRIPS; SIX OF THESE STRIPS WERE TESTED, AND FAILED TESTING READING LO ON ALL THREE BLOOD LEVELS CONFIRMING THE COMPLAINT. BOTTLE 2 WAS RETURNED WITH 50 STRIPS AND PASSED TESTING WITH NO FAILURES DETECTED. TWO BOTTLES OF RETAIN STRIPS WERE TESTED AS WELL. BOTTLE 1 OF RETAINS FAILED TESTING READING LO ON THE 150MG/DL AND 300MG/DL BLOOD LEVELS. BOTTLE 2 OF RETAINS PASSED TESTING WITH NO FAILURES DETECTED. DESICCANT TESTING WAS PERFORMED ON FAILED STRIP BOTTLES AND PASSED TESTING INDICATING MOISTURE INTRUSION IS NOT THE CAUSE OF THE OBSERVED STRIP FAILURE, INDICATING THAT USER ERROR IS MOST LIKELY NOT A FACTOR IN THE CONFIRMED FAILURE. COMPLAINT PRODUCTS WILL BE FORWARDED TO THE MANUFACTURER FOR FURTHER INVESTIGATION.

Description of Event or Problem · 0

CUSTOMER REPORTED ISSUES OF LOW BLOOD READINGS. COMPLAINT WAS REVIEWED FOR INVESTIGATION AND REPORTABILITY ON (B)(6) 2022. COMPLAINT WAS MARKED FOR INVESTIGATION AND DETERMINED NOT REPORTABLE PER ARKRAY'S PER INTERNAL PROCEDURES. ON (B)(6) 2022, RETURNED STRIPS FAILED TESTING BY GENERATING LOW RESULTS OUT OF SPECIFICATION. THE STRIPS GAVE LOW READINGS, MAKING THIS COMPLAINT REPORTABLE TO THE MANUFACTURER AS A MALFUNCTION. (B)(6) 2022 MARKS THE AWARE DATE FOR MDR FILING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2365881 RELION PRIME TEST STRIPS GLUCOSE OXIDASE, GLUCOSE CGA ARKRAY FACTORY USA, INC. 700100 122921B 00605388022943

Patients

Seq Age Sex Outcome Treatment
1 Male